Search Results - "Elaine Husni, M."

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis by Nissen, Steven E, Yeomans, Neville D, Solomon, Daniel H, Lüscher, Thomas F, Libby, Peter, Husni, M. Elaine, Graham, David Y, Borer, Jeffrey S, Wisniewski, Lisa M, Wolski, Katherine E, Wang, Qiuqing, Menon, Venu, Ruschitzka, Frank, Gaffney, Michael, Beckerman, Bruce, Berger, Manuela F, Bao, Weihang, Lincoff, A. Michael

“…This randomized trial involving patients with osteoarthritis or rheumatoid arthritis who were at increased cardiovascular risk showed the noninferiority of…”
Get full text

Comorbidities in Psoriatic Arthritis by Husni, M. Elaine, MD, MPH

“…Epidemiologic studies have shown that, in patients with psoriatic arthritis (PsA), associated comorbidities may occur more frequently than expected. This…”
Get full text

The psychosocial burden of psoriatic arthritis by Husni, M. Elaine, MD, MPH, Merola, Joseph F., MD, MMSc, Davin, Sara, PsyD, MPH

“…Abstract Objective To assess the psychosocial impact of psoriatic arthritis (PsA), describe how health-related quality of life (QoL) is affected in patients…”
Get full text

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis by Coates, Laura C., Kavanaugh, Arthur, Mease, Philip J., Soriano, Enrique R., Laura Acosta‐Felquer, Maria, Armstrong, April W., Bautista‐Molano, Wilson, Boehncke, Wolf‐Henning, Campbell, Willemina, Cauli, Alberto, Espinoza, Luis R., FitzGerald, Oliver, Gladman, Dafna D., Gottlieb, Alice, Helliwell, Philip S., Husni, M. Elaine, Love, Thorvardur J., Lubrano, Ennio, McHugh, Neil, Nash, Peter, Ogdie, Alexis, Orbai, Ana‐Maria, Parkinson, Andrew, O'Sullivan, Denis, Rosen, Cheryl F., Schwartzman, Sergio, Siegel, Evan L., Toloza, Sergio, Tuong, William, Ritchlin, Christopher T.

“…Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of…”
Get full text

Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis by Chandrasekharan, Unnikrishnan M, Wang, Zeneng, Wu, Yuping, Wilson Tang, W H, Hazen, Stanley L, Wang, Sihe, Elaine Husni, M

“…Rheumatoid arthritis (RA) patients are at high risk of developing cardiovascular disease (CVD). In RA, chronic inflammation may lead to endothelial…”
Get full text

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease by Helliwell, Philip, Coates, Laura C, FitzGerald, Oliver, Nash, Peter, Soriano, Enrique R, Elaine Husni, M, Hsu, Ming-Ann, Kanik, Keith S, Hendrikx, Thijs, Wu, Joseph, Kudlacz, Elizabeth

“…The multiple disease domains affected in psoriatic arthritis (PsA) may make composite endpoints appropriate for assessing changes in disease activity over…”
Get full text

Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease by Walsh, Jessica A, Wan, Marilyn T, Willinger, Christine, Husni, M Elaine, Scher, Jose U, Reddy, Soumya M, Ogdie, Alexis

“…To examine the construct validity of Routine Assessment of Patient Index Data 3 (RAPID3) and Psoriatic Arthritis Impact of Disease (PsAID) in patients with…”
Get full text

Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis by Williams, Mia F, London, Daniel A, Husni, Elaine M, Navaneethan, Sankar, Kashyap, Sangeeta R

“…Abstract Background Observational studies have reported an association between type 2 diabetes and osteoarthritis (OA) development and progression. However no…”
Get full text

The impact of functional medicine on patient-reported outcomes in inflammatory arthritis: A retrospective study by Droz, Nicole, Hanaway, Patrick, Hyman, Mark, Jin, Yuxuan, Beidelschies, Michelle, Husni, M Elaine

“…Despite treatment advances for inflammatory arthritis, a significant amount of patients fail to achieve remission. Other modifiable factors such as diet,…”
Get full text

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis by Husni, M Elaine, Deodhar, Atul, Schwartzman, Sergio, Chakravarty, Soumya D, Hsia, Elizabeth C, Leu, Jocelyn H, Zhou, Yiying, Lo, Kim H, Kavanaugh, Arthur

“…Intravenous (IV) golimumab, a TNFi, is approved for treating rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). We analyzed…”
Get full text

What Clinical Factors Affect Length of Transition to Psoriatic Arthritis in Patients With Psoriasis? by Cheemalavagu, Shashank, Jin, Yuxuan, Husni, M. Elaine

“…Objective We aimed to identify clinical and demographic features associated with the interval between psoriasis (PsO) and psoriatic arthritis (PsA). Methods We…”
Get full text

Management of Concomitant Inflammatory Bowel Disease or Uveitis in Patients with Psoriatic Arthritis: An Updated Review Informing the 2021 GRAPPA Treatment Recommendations by Jadon, Deepak R, Corp, Nadia, van der Windt, Danielle A, Coates, Laura C, Soriano, Enrique R, Kavanaugh, Arthur, Raine, Tim, Rieder, Florian, Siebert, Stefan, Zummer, Michel, Schwartzman, Sergio, Rosenbaum, James T, Michelsen, Brigitte, Laxminarayan, Ramasharan, Wu, Dongze, Gupta, Latika, Ng, Beverly, Jethwa, Hannah, De Windt, Nick, Gudu, Tania, Hutton, Joseph, O'Sullivan, Denis, Luchetti, Michele M, Stoll, Matthew, Singh, Jasvinder A, Peluso, Rosario, Rademacher, Judith, Husni, M Elaine

“…Several advanced therapies have been licensed across the related conditions of psoriatic arthritis (PsA), Crohn disease (CD), ulcerative colitis (UC), and…”
Get full text

Comparison of US patient, rheumatologist, and dermatologist perceptions of psoriatic disease symptoms: results from the DISCONNECT study by Husni, M Elaine, Fernandez, Anthony, Hauber, Brett, Singh, Rakesh, Posner, Joshua, Sutphin, Jessie, Ganguli, Arijit

“…The perceived bother of skin and joint-related manifestations of psoriatic disease may differ among patients, rheumatologists, and dermatologists. This study…”
Get full text

Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial by Kavanaugh, Arthur, Husni, M Elaine, Harrison, Diane D, Kim, Lilianne, Lo, Kim Hung, Noonan, Lenore, Hsia, Elizabeth C

“…Evaluate effects of intravenous (IV) golimumab (GOL) on radiographic progression in psoriatic arthritis (PsA). This phase III, randomized, double-blind,…”
Get full text

Act1 is a negative regulator in T and B cells via direct inhibition of STAT3 by Zhang, Cun-Jin, Wang, Chenhui, Jiang, Meiling, Gu, Chunfang, Xiao, Jianxin, Chen, Xing, Martin, Bradley N., Tang, Fangqiang, Yamamoto, Erin, Xian, Yibo, Wang, Han, Li, Fengling, Sartor, R. Balfour, Smith, Howard, Husni, M. Elaine, Shi, Fu-Dong, Gao, Ji, Carman, Julie, Dongre, Ashok, McKarns, Susan C., Coppieters, Ken, Jørgensen, Trine N., Leonard, Warren J., Li, Xiaoxia

“…Although Act1 (adaptor for IL-17 receptors) is necessary for IL-17-mediated inflammatory responses, Act1 - (but not Il17ra- , Il17rc- , or Il17rb -) deficient…”
Get full text

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial by Solomon, Daniel H, Libby, Peter, Yeomans, Neville D, Wang, Qiuqing, Wolski, Kathy E, Nissen, Steven E, Husni, M Elaine

“…Abstract Objective Guidelines exist for the use of low-dose aspirin in the general population for primary cardiovascular (CV) prevention, but the risk-benefit…”
Get full text

Relationship Between Metabolic Syndrome and Carotid Intima‐Media Thickness: Cross‐Sectional Comparison Between Psoriasis and Psoriatic Arthritis by Lin, Yih Chang, Dalal, Deepan, Churton, Sarah, Brennan, Danielle M., Korman, Neil J., Kim, Esther S. H., Husni, M. Elaine

“…Objective To determine the differences in carotid intima‐media thickness (CIMT) between patients with psoriatic diseases with and without metabolic syndrome…”
Get full text

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial by Mease, Philip, Husni, M Elaine, Kafka, Shelly, Chakravarty, Soumya D, Harrison, Diane D, Lo, Kim Hung, Xu, Stephen, Hsia, Elizabeth C, Kavanaugh, Arthur

“…In the GO-VIBRANT trial of intravenous golimumab in psoriatic arthritis (PsA), golimumab significantly inhibited radiographic progression. In post hoc…”
Get full text

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial by Ogdie, Alexis, Walsh, Jessica A., Chakravarty, Soumya D., Peterson, Steven, Lo, Kim Hung, Kim, Lilianne, Li, Nan, Hsia, Elizabeth C., Chan, Eric K. H., Kavanaugh, Arthur, Husni, M. Elaine

“…Introduction/objectives To evaluate changes in health-related quality of life (HRQoL) and productivity following treatment with intravenous (IV) golimumab in…”
Get full text

Comprehensive Assessment of the Psoriasis Patient (CAPP): A Report from the GRAPPA 2015 Annual Meeting by Paek, So Yeon, Thompson, Jordan M, Qureshi, Abrar A, Merola, Joseph F, Husni, M Elaine

“…Outcome measures for psoriasis severity are complex because of the heterogeneous presentation of the disease. At the 2015 annual meeting of the Group for…”
Get full text